Samsung Medical Center acquires Asia’s first Leksell Gamma Knife Icon system

Elekta’s new stereotactic radiosurgery system enables Korean hospital to treat
wider range of brain disorders with ultrahigh precision
SEOUL, June 10, 2015 – Elekta has signed a contract with one of Korea’s most
advanced hospitals, Samsung Medical Center (SMC) in Seoul, to deliver the first
Leksell Gamma Knife® Icon™ (http://www.careforthebrain.com/) to Asia.

In order to contribute to improving the nation’s health through the best medical
service, SMC has chosen the most precise cranial radiosurgery device on the
market. Some of Icon’s key features include:

  · The option of frameless treatments with similar level of accuracy as with
frame-based treatments
  · An integrated image guidance system based on stereotactic Cone Beam CT
(CBCT)
  · Online Adaptive DoseControl™, a concept for continuous quality control that
involves both high-definition motion management and technology to verify that
the dose ends up in the right place.

Combined, these allow for virtually unlimited clinical and operational
flexibility. Even more types of indications can be treated with the same high
precision and efficiency that has earned Leksell Gamma Knife® its reputation.

“With Leksell Gamma Knife Icon, I can increase treatment efficiency while
minimizing toxicity to normal brain tissues,” says Dr. Jung-Il Lee, professor at
SMC’s department of neurosurgery. “Icon brings new possibilities to patients
with tumors that could not be operated on before.”

Professor Lee has treated more than 7,000 patients with Leksell Gamma Knife
since 2002 and will now pioneer the new potential that Icon brings.

“Outside China, SMC is one of the busiest Gamma Knife radiosurgery centers in
Asia,” says Per Nylund, Elekta’s Business Marketing Director for Neuroscience in
Asia. “Furthermore, SMC is an active research center and frequently publishes
scientific articles within the field of radiosurgery. We are delighted that
Professor Lee and SMC are the first in the region to choose Leksell Gamma Knife
Icon to enhance their operational efficiency.”

Leksell Gamma Knife Icon is CE marked. Icon is not approved in all markets and
is not for sale or distribution in the US. Icon was introduced for the first
time in Asia at the 12th International Stereotactic Radiosurgery Society
Congress in Yokohama, Japan, June 7-11, 2015.


# # #

For further information, please contact:
Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242, e-mail: gert.vansanten@elekta.com
Time zone: CET: Central European Time

Johan Andersson, Director, Investor Relations, Elekta AB
Tel: +46 702 100 451, e-mail: johan.andersson@elekta.com
Time zone: CET: Central European Time

The above information is such that Elekta AB (publ) shall make public in
accordance with the Securities Market Act and/or the Financial Instruments
Trading Act. The information was published at 15:00 CET on June 10, 2015.

About Elekta
Elekta is a human care company pioneering significant innovations and clinical
solutions for treating cancer and brain disorders. The company develops
sophisticated, state-of-the-art tools and treatment planning systems for
radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing
software systems across the spectrum of cancer care. Stretching the boundaries
of science and technology, providing intelligent and resource-efficient
solutions that offer confidence to both health care providers and patients,
Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000
hospitals worldwide. Elekta employs around 3,800 employees globally. The
corporate headquarters is located in Stockholm, Sweden, and the company is
listed on NASDAQ Stockholm. Website: www.elekta.com.